secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAXCYTE, INC. (MXCT)
CIK:        0001287098
Form:       8-K
Filed at:   2025-09-22T23:59:59+00:00
Accession:  0001104659-25-092162
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.05, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MaxCyte cuts ~34% of workforce, expects $13.6M annual savings; reiterates 2025 revenue outlook.
--------------------------------------------------------------------------------

- Workforce reduction of ~34% globally, including EOR arrangements; expects pre-tax cash charges of $2.9M.
- Annualized cost savings estimated at $13.6M, beginning in Q4 2025.
- Reiterates 2025 core revenue flat to down ~10% YoY; SPL program revenue ~$5M.
- Expects year-end cash, equivalents, and investments to be at least $155M.
- Implementation substantially complete by November 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1287098/000110465925092162/0001104659-25-092162-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1287098/000110465925092162/mxct-20250922x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-092162

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer